Q2 Earnings Estimate for IRWD Issued By Zacks Research
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Free Report) – Analysts at Zacks Research issued their Q2 2027 EPS estimates for Ironwood Pharmaceuticals in a report released on Monday, September 8th. Zacks Research analyst Team forecasts that the biotechnology company will post earnings of $0.01 per share for the quarter. Zacks Research has a “Hold” rating on […]
More Stories
Shooting at Poland Market Kills at Least 5
By Jacki Thrapp At least five people were killed when a gunman opened fire at a market in Poland on...
Portugal’s Cristiano Ronaldo Announces International Retirement
By The Associated Press Cristiano Ronaldo won’t play for Portugal anymore, ending on Thursday a career that spanned six World...
IRS Unveils 2027 Federal Income Tax Brackets
By Naveen Athrappully Federal tax authorities announced higher income tax brackets and other annual inflation adjustments for tax year 2027....
US Economy Adds 165,000 New Jobs in October, Unemployment Rate Dips to 4.1 Percent
By Andrew Moran Employment conditions strengthened in October as job growth blew past economists’ forecasts and the unemployment rate unexpectedly...
Trump Blames Democrats’ Midterm Victory for Stock Market Losses
By Jack Phillips President Donald Trump on Thursday said a stock market drop that day was due to Democrats winning...
Victor Davis Hanson Discusses What’s Next for GOP, Possible 2028 Contenders
By Timothy Frudd and Jan Jekielek President Donald Trump can still wield considerable political power over the next two years...